Literature DB >> 27942970

Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

Anna Gluba-Brzózka1,2, Beata Franczyk3, Maciej Banach4,5, Magdalena Rysz-Górzyńska6,4.   

Abstract

BACKGROUND: Significantly increased cardiovascular mortality in patients with chronic kidney (CKD) disease cannot be explained by traditional risk factors. Recent studies revealed that the quality of HDL and LDL cholesterol may be more important than their serum levels. The aim of this study was to assess which LDL and HDL subfractions were more abundant in end-stage renal disease (ESRD) patients and to analyse whether subfraction distribution could be associated with accelerated atherosclerotic processes.
METHODS: This study included 50 ESRD patients undergoing dialysis and 20 healthy volunteers. LDL and HDL subfractions were analysed in serum with the use of Lipoprint system. All patients had intima-media thickness (IMT) measured.
RESULTS: Statistically significant differences in subfractions between control and study group were observed in case of: HDL1 (p < 0.0001), HDL2 (p = 0.009), HDL3 (p < 0.0001), HDL4 (p = 0.003), HDL5 (p = 0.01), HDL7 (p < 0.0001), HDL8 (p < 0.0001), HDL9 (p < 0.0001), HDL10 (p < 0.0001), large HDL (p < 0.0001), HDL Small (p < 0.0001) as well as IDL-B (p = 0.014), IDLA (p = 0.011), LDL2 (p = 0.007). Significant differences were also observed in HDL and LDL subfraction distribution between haemodialysis patients with normal and increased IMT: HDL6 (p = 0.020), HDL Large (HDL1-3) (p = 0.017), HDL Intermediate (HDL4-7) (p = 0.017).
CONCLUSIONS: This study revealed that ESRD influenced HDL subfractions. In HD patients, large HDL subfractions are more abundant while small HDL fraction is more frequent in healthy persons. It failed to show the influence of end-stage disease on LDL subfraction levels. Shift in HDL subfractions might be responsible for the increased risk of atherosclerosis in CKD patients.

Entities:  

Keywords:  Atherosclerosis; End-stage renal disease; HDL; Intima-media thickness; LDL; Subfractions

Mesh:

Substances:

Year:  2016        PMID: 27942970     DOI: 10.1007/s11255-016-1466-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  47 in total

1.  Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.

Authors:  Nosratola D Vaziri; Kaveh Navab; Pavan Gollapudi; Hamid Moradi; Madeleine V Pahl; Cyril H Barton; Alan M Fogelman; Mohamad Navab
Journal:  J Natl Med Assoc       Date:  2011-06       Impact factor: 1.798

2.  Effects of low-dose simvastatin on the distribution of plasma cholesterol and oxidized low-density lipoprotein in three ultra-centrifugally separated low-density lipoprotein subfractions: 12- month, open-label trial.

Authors:  Yasuhiko Homma; Ichiro Michishita; Hiroshi Hayashi; Hiroshi Shigematsu
Journal:  J Atheroscler Thromb       Date:  2010-07-13       Impact factor: 4.928

3.  Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.

Authors:  Laurent Camont; Marie Lhomme; Fabiana Rached; Wilfried Le Goff; Anne Nègre-Salvayre; Robert Salvayre; Catherine Calzada; Michel Lagarde; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-03       Impact factor: 8.311

4.  Uremia alters HDL composition and function.

Authors:  Michael Holzer; Ruth Birner-Gruenberger; Tatjana Stojakovic; Dalia El-Gamal; Veronika Binder; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2011-07-29       Impact factor: 10.121

5.  Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.

Authors:  Hamid Moradi; Elani Streja; Moti L Kashyap; Nosratola D Vaziri; Gregg C Fonarow; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

6.  Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study.

Authors:  Austin G Stack; Wendy E Bloembergen
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

7.  Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans.

Authors:  Shusaku Maeda; Shuhei Nakanishi; Masayasu Yoneda; Tomokazu Awaya; Kiminori Yamane; Tsutomu Hirano; Nobuoki Kohno
Journal:  J Atheroscler Thromb       Date:  2011-12-21       Impact factor: 4.928

Review 8.  Metabolic origins and clinical significance of LDL heterogeneity.

Authors:  Kaspar K Berneis; Ronald M Krauss
Journal:  J Lipid Res       Date:  2002-09       Impact factor: 5.922

9.  Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.

Authors:  Elda Favari; Laura Calabresi; Maria Pia Adorni; Wendy Jessup; Sara Simonelli; Guido Franceschini; Franco Bernini
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

Review 10.  HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Authors:  Suetonia C Palmer; Sankar D Navaneethan; Jonathan C Craig; David W Johnson; Vlado Perkovic; Jorgen Hegbrant; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2014-05-31
View more
  6 in total

Review 1.  The effect of chronic kidney disease on lipid metabolism.

Authors:  Neris Dincer; Tuncay Dagel; Baris Afsar; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2018-12-05       Impact factor: 2.370

Review 2.  HDL in CKD-The Devil Is in the Detail.

Authors:  Florian Kronenberg
Journal:  J Am Soc Nephrol       Date:  2018-02-22       Impact factor: 10.121

3.  ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients.

Authors:  Alicja E Grzegorzewska; Leszek Niepolski; Monika K Świderska; Adrianna Mostowska; Ireneusz Stolarek; Wojciech Warchoł; Marek Figlerowicz; Paweł P Jagodziński
Journal:  BMC Med Genet       Date:  2018-11-09       Impact factor: 2.103

4.  Effect of renal function on high-density lipoprotein particles in patients with coronary heart disease.

Authors:  Long Jieni; Xue Yazhi; Zeng Xiaorong; Liu Dan; Ma Yusheng; Rao Jiahuan; Zhang Bin; Li Li; Guo Zhigang
Journal:  BMC Cardiovasc Disord       Date:  2021-11-12       Impact factor: 2.298

Review 5.  Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?

Authors:  Susana Coimbra; Flávio Reis; Maria João Valente; Susana Rocha; Cristina Catarino; Petronila Rocha-Pereira; Maria Sameiro-Faria; Elsa Bronze-da-Rocha; Luís Belo; Alice Santos-Silva
Journal:  Biomedicines       Date:  2021-05-16

6.  Relationship between subclasses low-density lipoprotein and carotid plaque.

Authors:  Zhanhai Pan; Huiwen Guo; Qingqing Wang; Sha Tian; Xiaoxuan Zhang; Chengbo Li; Zheng Ma
Journal:  Transl Neurosci       Date:  2022-03-03       Impact factor: 1.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.